Whereas the importance of MHC-I restricted CD8+T cell responses to anti-tumor immunity is undisputed, it is also well established that CD8+ T cell responses themselves are critically dependent on the availability of CD4+ T cell help [(67–71), reviewed in (72)]. The gene discussed is CD8A; the disease is neoplasm.